Key Boston Scientific executive is leaving

One of Boston Scientific Corp.'s top executives, chief medical officer Mary Russell, has resigned and will leave in July, a spokesman said. Russell oversees clinical and regulatory affairs for the company's $6 billion portfolio of medical devices. The Natick company did not offer a reason for Russell's departure. Russell, a cardiologist, joined the Natick company six years ago and helped shepherd the company's Taxus drug-eluting stent through its clinical trials. Taxus sales now account for almost $3 billion annually, making it one of the top-selling medical devices in the world. Russell, 51, gained significant new duties in 2004 when she was put in charge of regulatory affairs as well as clinical testing.
(By Stephen Heuser, Globe Staff)

•  Previous Entry
• Next Entry